Head and Neck Squamous Cell Carcinoma: Update on Epidemiology, Diagnosis, and Treatment

Shanthi Marur, Arlene A. Forastiere

Research output: Contribution to journalArticle

Abstract

Squamous cell carcinoma arises from multiple anatomic subsites in the head and neck region. The risk factors for development of cancers of the oral cavity, oropharynx, hypopharynx, and larynx include tobacco exposure and alcohol dependence, and infection with oncogenic viruses is associated with cancers developing in the nasopharynx, palatine, and lingual tonsils of the oropharynx. The incidence of human papillomavirus-associated oropharyngeal cancer is increasing in developed countries, and by 2020, the annual incidence could surpass that of cervical cancer. The treatment for early-stage squamous cell cancers of the head and neck is generally single modality, either surgery or radiotherapy. The treatment for locally advanced head and neck cancers is multimodal, with either surgery followed by adjuvant radiation or chemoradiation as indicated by pathologic features or definitive chemoradiation. For recurrent disease that is not amenable to a salvage local or regional approach and for metastatic disease, chemotherapy with or without a biological agent is indicated. To date, molecular testing has not influenced treatment selection in head and neck cancer. This review will focus on the changing epidemiology, advances in diagnosis, and treatment options for squamous cell cancers of the head and neck, along with data on risk stratification specific to oropharyngeal cancer, and will highlight the direction of current trials.

Original languageEnglish (US)
Pages (from-to)386-396
Number of pages11
JournalMayo Clinic Proceedings
Volume91
Issue number3
DOIs
StatePublished - Mar 1 2016

Fingerprint

Head and Neck Neoplasms
Epidemiology
Oropharyngeal Neoplasms
Squamous Cell Neoplasms
Oropharynx
Hypopharynx
Oncogenic Viruses
Tobacco Use Disorder
Nasopharynx
Mouth Neoplasms
Palatine Tonsil
Incidence
Biological Factors
Therapeutics
Larynx
Tongue
Developed Countries
Uterine Cervical Neoplasms
Alcoholism
Mouth

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Head and Neck Squamous Cell Carcinoma : Update on Epidemiology, Diagnosis, and Treatment. / Marur, Shanthi; Forastiere, Arlene A.

In: Mayo Clinic Proceedings, Vol. 91, No. 3, 01.03.2016, p. 386-396.

Research output: Contribution to journalArticle

@article{d53f988d081c4b88ab641235c81c23ce,
title = "Head and Neck Squamous Cell Carcinoma: Update on Epidemiology, Diagnosis, and Treatment",
abstract = "Squamous cell carcinoma arises from multiple anatomic subsites in the head and neck region. The risk factors for development of cancers of the oral cavity, oropharynx, hypopharynx, and larynx include tobacco exposure and alcohol dependence, and infection with oncogenic viruses is associated with cancers developing in the nasopharynx, palatine, and lingual tonsils of the oropharynx. The incidence of human papillomavirus-associated oropharyngeal cancer is increasing in developed countries, and by 2020, the annual incidence could surpass that of cervical cancer. The treatment for early-stage squamous cell cancers of the head and neck is generally single modality, either surgery or radiotherapy. The treatment for locally advanced head and neck cancers is multimodal, with either surgery followed by adjuvant radiation or chemoradiation as indicated by pathologic features or definitive chemoradiation. For recurrent disease that is not amenable to a salvage local or regional approach and for metastatic disease, chemotherapy with or without a biological agent is indicated. To date, molecular testing has not influenced treatment selection in head and neck cancer. This review will focus on the changing epidemiology, advances in diagnosis, and treatment options for squamous cell cancers of the head and neck, along with data on risk stratification specific to oropharyngeal cancer, and will highlight the direction of current trials.",
author = "Shanthi Marur and Forastiere, {Arlene A.}",
year = "2016",
month = "3",
day = "1",
doi = "10.1016/j.mayocp.2015.12.017",
language = "English (US)",
volume = "91",
pages = "386--396",
journal = "Mayo Clinic Proceedings",
issn = "0025-6196",
publisher = "Elsevier Science",
number = "3",

}

TY - JOUR

T1 - Head and Neck Squamous Cell Carcinoma

T2 - Update on Epidemiology, Diagnosis, and Treatment

AU - Marur, Shanthi

AU - Forastiere, Arlene A.

PY - 2016/3/1

Y1 - 2016/3/1

N2 - Squamous cell carcinoma arises from multiple anatomic subsites in the head and neck region. The risk factors for development of cancers of the oral cavity, oropharynx, hypopharynx, and larynx include tobacco exposure and alcohol dependence, and infection with oncogenic viruses is associated with cancers developing in the nasopharynx, palatine, and lingual tonsils of the oropharynx. The incidence of human papillomavirus-associated oropharyngeal cancer is increasing in developed countries, and by 2020, the annual incidence could surpass that of cervical cancer. The treatment for early-stage squamous cell cancers of the head and neck is generally single modality, either surgery or radiotherapy. The treatment for locally advanced head and neck cancers is multimodal, with either surgery followed by adjuvant radiation or chemoradiation as indicated by pathologic features or definitive chemoradiation. For recurrent disease that is not amenable to a salvage local or regional approach and for metastatic disease, chemotherapy with or without a biological agent is indicated. To date, molecular testing has not influenced treatment selection in head and neck cancer. This review will focus on the changing epidemiology, advances in diagnosis, and treatment options for squamous cell cancers of the head and neck, along with data on risk stratification specific to oropharyngeal cancer, and will highlight the direction of current trials.

AB - Squamous cell carcinoma arises from multiple anatomic subsites in the head and neck region. The risk factors for development of cancers of the oral cavity, oropharynx, hypopharynx, and larynx include tobacco exposure and alcohol dependence, and infection with oncogenic viruses is associated with cancers developing in the nasopharynx, palatine, and lingual tonsils of the oropharynx. The incidence of human papillomavirus-associated oropharyngeal cancer is increasing in developed countries, and by 2020, the annual incidence could surpass that of cervical cancer. The treatment for early-stage squamous cell cancers of the head and neck is generally single modality, either surgery or radiotherapy. The treatment for locally advanced head and neck cancers is multimodal, with either surgery followed by adjuvant radiation or chemoradiation as indicated by pathologic features or definitive chemoradiation. For recurrent disease that is not amenable to a salvage local or regional approach and for metastatic disease, chemotherapy with or without a biological agent is indicated. To date, molecular testing has not influenced treatment selection in head and neck cancer. This review will focus on the changing epidemiology, advances in diagnosis, and treatment options for squamous cell cancers of the head and neck, along with data on risk stratification specific to oropharyngeal cancer, and will highlight the direction of current trials.

UR - http://www.scopus.com/inward/record.url?scp=84959349850&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84959349850&partnerID=8YFLogxK

U2 - 10.1016/j.mayocp.2015.12.017

DO - 10.1016/j.mayocp.2015.12.017

M3 - Article

C2 - 26944243

AN - SCOPUS:84959349850

VL - 91

SP - 386

EP - 396

JO - Mayo Clinic Proceedings

JF - Mayo Clinic Proceedings

SN - 0025-6196

IS - 3

ER -